Literature DB >> 12919996

Poor glycaemic control caused by insulin induced lipohypertrophy.

Tahseen A Chowdhury1, Valerie Escudier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919996      PMCID: PMC1126795          DOI: 10.1136/bmj.327.7411.383

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude.

Authors:  T M Wallace; D R Matthews
Journal:  QJM       Date:  2000-06

2.  Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).

Authors:  N A Roper; R W Bilous
Journal:  Diabet Med       Date:  1998-12       Impact factor: 4.359

3.  Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.

Authors:  P G McNally; N I Jowett; J J Kurinczuk; R W Peck; J R Hearnshaw
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

4.  Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.

Authors:  K Raile; V Noelle; R Landgraf; H P Schwarz
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

5.  Diabetic lipohypertrophy delays insulin absorption.

Authors:  R J Young; W J Hannan; B M Frier; J M Steel; L J Duncan
Journal:  Diabetes Care       Date:  1984 Sep-Oct       Impact factor: 19.112

6.  Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.

Authors:  H Hauner; B Stockamp; B Haastert
Journal:  Exp Clin Endocrinol Diabetes       Date:  1996       Impact factor: 2.949

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

  7 in total
  29 in total

1.  Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors.

Authors:  Magdy A Omar; Ahmed A El-Kafoury; Ramy I El-Araby
Journal:  BMC Res Notes       Date:  2011-08-12

2.  Cautionary tale: subdural haematoma following frequent hypoglycaemia from insulin-induced lipohypertrophy.

Authors:  Ian S Boon; Mujahid A Saeed
Journal:  BMJ Case Rep       Date:  2015-12-01

3.  Tissue Response to Subcutaneous Infusion Catheter.

Authors:  Ershuai Zhang; Zhiqiang Cao
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

4.  Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes.

Authors:  Ananda Basu; Simmi Dube; Sona Veettil; Michael Slama; Yogish C Kudva; Thomas Peyser; Rickey E Carter; Claudio Cobelli; Rita Basu
Journal:  J Diabetes Sci Technol       Date:  2014-10-10

5.  Unexplained Persistent Hyperglycaemia in a Type I Diabetes Patient - Is Injection Site Lipohypertrophy the Cause?

Authors:  Ranjana Ajit Sahasrabudhe; Tejas Yashwant Limaye; Vidya Sanjay Gokhale
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 6.  Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?

Authors:  Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

7.  Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus.

Authors:  F Bertuzzi; E Meneghini; E Bruschi; L Luzi; M Nichelatti; O Epis
Journal:  J Endocrinol Invest       Date:  2017-04-27       Impact factor: 4.256

8.  Insulin Injection Site Adverse Effect in a Type 1 Diabetes Patient: An Unusual Presentation.

Authors:  Ranjana Ajit Sahasrabudhe; Tejas Yashwant Limaye; Vidya Sanjay Gokhale
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 9.  Inhaled insulins.

Authors:  Sujoy Ghosh; Andrew Collier
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

10.  Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Authors:  Adam Mulka; Brianne E Lewis; Li Mao; Roshanak Sharafieh; Shereen Kesserwan; Rong Wu; Donald L Kreutzer; Ulrike Klueh
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.